US News & World Report: Immunotherapy and cancer, COVID-19
July 21, 2020
National media outlets report on new UC findings that show immunotherapy will not worsen complications for patients who have cancer and COVID-19.
July 21, 2020
National media outlets report on new UC findings that show immunotherapy will not worsen complications for patients who have cancer and COVID-19.
June 25, 2020
Fierce Biotech highlights a study by UC researchers which lays the foundation for using a combination immunotherapy in breast cancer.
September 9, 2020
Claudia Rebola is an associate professor and the associate dean for research at the University of Cincinnati’s College of Design, Architecture, Arts, and Planning. She is part of a UC team using innovation and design expertise to respond to COVID-19.
September 21, 2020
In The News: Sustainable processing delivers highest quality, minimizing odor and taste of fish oil. Researcher Harshita Kumari co-led study appears in Science of Food.
September 22, 2020
Drugs.com covers UC research looking at mortality in patients with cancer and COVID-19.
September 22, 2020
WVXU reports on a University of Cincinnati study showing cancer patients undergoing a combination of chemotherapy and immunotherapy one to three months before a COVID-19 diagnosis have a greater risk of death than patients who haven't undergone cancer treatment in the past year.
August 26, 2020
Janet Moore, a University of Cincinnati law professor and former public defense attorney, weighs in on the participatory defense model in this story by The Progressive.
August 26, 2020
Drugs.com reports on UC research that shows adolescents with generalized anxiety disorder may benefit from use of escitalopram.
September 2, 2020
Olugbenga Olowokure, MD, says it can be difficult to detect colon cancer in someone younger than 45 years old, which is when screenings are recommended.
September 3, 2020
Brett Kissela, MD, participates in COVID-19 vaccine trial at UC.